Keywords: تزریق aflibercept intravitreal; AMD; age-related macular degeneration; CNV; choroidal neovascularization; IAI; intravitreal aflibercept injection; ICGA; indocyanine green angiography; OCT; optical coherence tomography; PCV; polypoidal choroidal vasculopathy; PDT; photodynamic therapy; R
مقالات ISI تزریق aflibercept intravitreal (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: تزریق aflibercept intravitreal; 0.5q4; 0.5 mg intravitreal aflibercept injection every 4 weeks; 2q4; 2 mg intravitreal aflibercept injection every 4 weeks; 2q8; 2 mg intravitreal aflibercept injection every 8 weeks after 3 initial monthly injections; ANCHOR; Anti-VEGF Antibody for the T
Aflibercept for Previously Treated Macular Edema Associated with Central Retinal Vein Occlusions: 1-Year Results of the NEWTON Study
Keywords: تزریق aflibercept intravitreal; BCVA; best-corrected visual acuity; CME; cystoid macular edema; CRVO; central retinal vein occlusion; CST; central subfoveal retinal thickness; ETDRS; Early Treatment Diabetic Retinopathy Study; IAI; intravitreal aflibercept injection; PRN; pro re nata; S
Baseline Factors Affecting Changes in Diabetic Retinopathy Severity Scale Score After Intravitreal Aflibercept or Laser for Diabetic Macular Edema
Keywords: تزریق aflibercept intravitreal; BCVA; best-corrected visual acuity; BMI; body mass index; CST; central subfield thickness; DME; diabetic macular edema; DR; diabetic retinopathy; DRSS; Diabetic Retinopathy Severity Scale; HbA1c; hemoglobin A1c; IAI; intravitreal aflibercept injection; VE
Impact of Baseline Characteristics on Treatment Response to Intravitreal Aflibercept Injection for Wet Age-Related Macular Degeneration
Keywords: تزریق aflibercept intravitreal; AMD; age-related macular degeneration; ANCHOR; The Anti-Vascular Endothelial Growth Factor (VEGF) Antibody for the Treatment of Predominantly Classic Choroidal Neovascularization in AMD; BCVA; best-corrected visual acuity; CATT; The Comparison of Age-Rela
Outcomes of Diabetic Macular Edema Eyes with Limited Early Response in the VISTA and VIVID Studies
Keywords: تزریق aflibercept intravitreal; BCVA; best-corrected visual acuity; CI; confidence interval; CST; central subfield thickness; DME; diabetic macular edema; DRSS; Diabetic Retinopathy Severity Scale; IAI; intravitreal aflibercept injection; LS; least square; NPDR; nonproliferative diabeti
Aflibercept for Patients with Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in Germany
Keywords: تزریق aflibercept intravitreal; AURA; a retrospective noninterventional study to assess the effectiveness of existing anti-vascular endothelial growth factor treatment regimens in patients with wet age-related macular degeneration; COMPASS; study to assess the efficacy of treatment wi
Outcomes of Diabetic Macular Edema Patients by Baseline Hemoglobin A1c
Keywords: تزریق aflibercept intravitreal; BCVA; best-corrected visual acuity; CI; confidence interval; DME; diabetic macular edema; ETDRS; Early Treatment Diabetic Retinopathy Study; IAI; intravitreal aflibercept injection; VEGF; vascular endothelial growth factor;
Long-term Safety and Visual Outcome of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration
Keywords: تزریق aflibercept intravitreal; AMD; age-related macular degeneration; BCVA; best-corrected visual acuity; CRT; central retinal thickness; DA; disc area; IAI; intravitreal aflibercept injection;
Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion
Keywords: تزریق aflibercept intravitreal; AE; adverse event; BCVA; best-corrected visual acuity; BRVO; branch retinal vein occlusion; CRT; central retinal thickness; IAI; intravitreal aflibercept injection; ME; macular edema; NEI VFQ-25; National Eye Institute Visual Function Questionnaire-25; OC
Intravitreal Aflibercept Injection in Diabetic Macular Edema Patients with and without Prior Anti-Vascular Endothelial Growth Factor Treatment
Keywords: تزریق aflibercept intravitreal; BCVA; best-corrected visual acuity; CST; central subfield thickness; DME; diabetic macular edema; DRSS; Diabetic Retinopathy Severity Scale; ETDRS; Early Treatment Diabetic Retinopathy Study; IAI; intravitreal aflibercept injection; SD; standard deviation
Differential Response to Anti-VEGF Regimens in Age-Related Macular Degeneration Patients with Early Persistent Retinal Fluid
Keywords: تزریق aflibercept intravitreal; BCVA; best-corrected visual acuity; CATT; Comparison of Age-related Macular Degeneration Treatment Trials; CI; confidence interval; IAI; intravitreal aflibercept injection; NVAMD; neovascular age-related macular degeneration; OCT; optical coherence tomogr
Intravitreal Aflibercept for Diabetic Macular Edema
Keywords: تزریق aflibercept intravitreal; aLOCF; last observation carried forward, including measurements after additional or PRN treatment was given; AMD; age-related macular degeneration; BCVA; best-corrected visual acuity; CST; central subfield thickness; DME; diabetic macular edema; DRSS; Dia
Comprehensive Review of Ocular and Systemic Safety Events with Intravitreal Aflibercept Injection in Randomized Controlled Trials
Keywords: تزریق aflibercept intravitreal; APTC; Anti-Platelet Trialists Collaboration; ATE; arterial thromboembolic event; BRVO; branch retinal vein occlusion; CI; confidence interval; CRVO; central retinal vein occlusion; DME; diabetic macular edema; HTN; hypertension; IAI; intravitreal afliberc
Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion
Keywords: تزریق aflibercept intravitreal; AE; adverse event; BCVA; best-corrected visual acuity; BRVO; branch retinal vein occlusion; CRT; central retinal thickness; CRVO; central retinal vein occlusion; ETDRS; Early Treatment Diabetic Retinopathy Study; HRVO; hemi-retinal vein occlusion; IAI; in
Intravitreal Aflibercept for Diabetic Macular Edema
Keywords: تزریق aflibercept intravitreal; 2q4; 2 mg every 4 weeks; 2q8; 2 mg every 8 weeks after 5 initial monthly doses; AE; adverse event; aLOCF; last observation carried forward, including measurements after rescue treatment was given; BCVA; best-corrected visual acuity; CST; central (optical
Intravitreal Aflibercept Injection for Macular Edema Due to Central Retinal Vein Occlusion
Keywords: تزریق aflibercept intravitreal; BCVA; best-corrected visual acuity; CRT; central retinal thickness; CRUISE; Central Retinal Vein Occlusion Study: Evaluation of Efficacy and Safety; CRVO; central retinal vein occlusion; IAI; intravitreal aflibercept injection; NEI VFQ-25; National Eye In
Intravitreal Aflibercept for Diabetic Macular Edema
Keywords: تزریق aflibercept intravitreal; aLOCF; last observation carried forward, including values after additional treatment was given; BCVA; best-corrected visual acuity; CST; central (optical coherence tomography) subfield thickness; DME; diabetic macular edema; DRCR.net; Diabetes Retinopathy